跳至主要内容
临床试验/ISRCTN87948966
ISRCTN87948966已完成不适用

Intravenous iron sucrose (+/- erythropoetin) versus oral iron for correction of post-operative anaemia in women with gynaecological malignancies

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 个研究点目标入组 45 人开始时间: 2005年9月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 45 patients in 3 groups.
  • 1. Pre-operative inclusion criteria:
  • 1.1. All patients who are due to undergo major gynae-oncological surgery
  • 1.2. Aged greater than 18 years
  • 2. Post-operative inclusion criteria:
  • 2.1. Iron deficiency type anaemia due to peri-operative blood loss
  • 2.2. Haemoglobin (Hb) less than 10 g/dl on day 1 following surgery

排除标准

  • 1. Pre-operative exclusion criteriaL
  • 1.1. Patients requiring peri-operative therapeutic anti-coagulant therapy
  • 1.2. Pre-operative anaemia
  • 1.3. Liver disease
  • 1.4. Chronic renal failure
  • 1.5. Uncontrolled hypertension
  • 1.6. Ischaemic heart disease requiring a transfusion threshold above 7 g/dl
  • 1.7. History of anaphylaxis to oral iron sulphate, iron sucrose or epoietin alpha
  • 2. Post-operative exclusion criteria:
  • 2.1. Severe anaemia requiring transfusion of red cells: Day 1 [Hb] less than 7
  • 2.2. Massive blood transfusion associated with disseminated intravascular coagulation (DIC)
  • 2.3. Continuing requirement for blood product administration

研究者

发起方
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)

相似试验